Mitsubishi UFJ Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,486
Closed -$277K 1135
2023
Q1
$277K Buy
3,486
+242
+7% +$17.2K ﹤0.01% 987
2022
Q4
$222K Sell
3,244
-300
-8% -$17.6K ﹤0.01% 1011
2022
Q3
$177K Buy
3,544
+240
+7% +$12.9K ﹤0.01% 1039
2022
Q2
$184K Sell
3,304
-2,456
-43% -$136K ﹤0.01% 1050
2022
Q1
$320K Buy
5,760
+1,060
+23% +$54.4K ﹤0.01% 993
2021
Q4
$256K Buy
+4,700
New +$255K ﹤0.01% 1041

Other funds holding NVO

Mitsubishi UFJ Asset Management's NVO Position: Q2 2023 in Review

Mitsubishi UFJ Asset Management sold out of Novo Nordisk (NVO) in Q2 2023, closing a stake of 3,486 shares — an estimated $277K sold.

Mitsubishi UFJ Asset Management first reported a position in NVO in Q4 2021 and held it in 6 quarters. The position peaked at $320K in Q1 2022. 1,197 funds tracked by Wall St. Rank hold NVO as of Q2 2023.

  • Mitsubishi UFJ Asset Management reported no remaining Novo Nordisk position as of Q2 2023 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 3,486 Novo Nordisk shares in Q2 2023, an estimated $277K.
  • Mitsubishi UFJ Asset Management first reported a position in Novo Nordisk in Q4 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Asset Management's Novo Nordisk position peaked at $320K in Q1 2022.
  • 1,197 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2023, filed 9 Aug 2023.